Intralesional Bleomycin Sclerotherapy for Low-Flow Vascular Malformations of the Head and Neck

This study evaluated lesion volume reduction after intralesional bleomycin sclerotherapy in patients with low-flow vascular malformations of the head and neck, and identified predictors of treatment response. Twenty patients were enrolled across three Iraqi teaching hospitals and treated with intralesional bleomycin. Lesion volume was assessed by ultrasound or MRI at baseline and four weeks after the final treatment session.

NCT Number	NCT07728825
Lead Sponsor	University Of Anbar
Conditions	Vascular Malformations, Venous Malformation, Lymphatic Malformation
Enrollment	20 participants
Start Date	2025-08-25
Primary Completion	2026-04-16 (estimated)
Study Completion	2026-04-26 (estimated)
Updated on ClinicalTrials.gov	2026-07-27